Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the C-Early Ra ...
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2660
https://www.valueinhealthjournal.com/article/S1098-3015(15)04736-1/fulltext
Title :
Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the C-Early Ra ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04736-1&doi=10.1016/j.jval.2015.09.2660
First page :
A707
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2063